Nanoco Regulatory News (NANO)

6 Jul 2007 16:45

Evolutec Group PLC06 July 2007 EVOLUTEC GROUP PLC (the "Company") 6 July 2007 Results of Extraordinary General Meeting ("EGM") and changes to the Board At today's EGM a resolution to adjourn the meeting was not passed and as aconsequence, and as anticipated by the Board in its letter to shareholders dated2 July 2007, the Resolutions to approve the voluntary winding up of the Companywere put to the EGM and were not approved. As planned, Nicholas Badman, Dr Mark Carnegie Brown, John Burke and MalcolmDarvell have stood down from the Board with effect from the end of the EGM. DrDavid Bloxham and Graeme Hart will remain on the Board and the Company willproceed as an investment company with an investment strategy to seek a singleinvestment, most probably of a UK or European business, in either thetechnology, healthcare or service related sectors. It is expected that the two Directors proposed by Gartmore Investment Limited,Mark Hawtin and Gordon Hall, will be appointed to the Board shortly. Enquiries: Evolutec 0118 922 4480David Bloxham, Chairman Numis Securities Limite 020 7260 1000Michael Meade Financial Dynamics 020 7831 3113David YatesBen Brewerton This information is provided by RNS The company news service from the London Stock Exchange